MCL - 368-1978-15-177

Download Division | View Division Index
Chapter 333
Act 368 of 1978
368-1978-15
Previous Division
Next Division
PUBLIC HEALTH CODE (EXCERPT)
Act 368 of 1978
Part 177
PHARMACY PRACTICE AND DRUG CONTROL
Document Type Description
Section 333.17701 Section Meanings of words and phrases; general definitions and principles of construction.
Section 333.17702 Section Definitions; A to C.
Section 333.17703 Section Definitions; D, E.
Section 333.17704 Section Definitions; F to I.
Section 333.17705 Section Definitions; L.
Section 333.17706 Section Definitions; M, O.
Section 333.17707 Section Definitions; P.
Section 333.17708 Section Definitions; P to R; limitation on prescription of pharmacological agents.
Section 333.17709 Section Definitions; S to W.
Section 333.17711 Section Practice of pharmacy or pharmacy technician; license or authorization required; use of words, titles, or letters.
Section 333.17713 Section Temporary regulations of pharmacists and prescriptions during qualified order or declaration; definitions.
Section 333.17721 Section Michigan board of pharmacy; creation; membership; terms.
Section 333.17722 Section Michigan board of pharmacy; duties generally.
Section 333.17723 Section Pilot project to maintain or improve patient care in delivery of pharmacy services and improving patient outcomes.
Section 333.17724 Section Ordering and administration of qualified immunizing agent by pharmacist; requirements and duties; promulgation of rules; exception emergency order; definitions.
Section 333.17724a Section Ordering and administration of qualified laboratory tests by pharmacist; requirements and duties; promulgation of rules; exceptions; "qualified laboratory test" defined.
Section 333.17726 Section Certificate of licensure; issuance.
Section 333.17731 Section Renewal of pharmacist or pharmacy technician license; continuing education; rules.
Section 333.17733 Section Relicensure of pharmacist; requirements.
Section 333.17737 Section Rules establishing standards for internship program; limited license required.
Section 333.17739 Section Pharmacy technician; functions; licensure.
Section 333.17739a Section Pharmacy technician; licensure; requirements; exemption from certain requirements.
Section 333.17739b Section Pharmacy technician; temporary license.
Section 333.17739c Section Pharmacy technician; limited license.
Section 333.17741 Section Pharmacy license required; personal charge of pharmacy by pharmacist; responsibility for compliance with laws; control and personal charge of pharmacy services; remote pharmacy exception; effect of violation on pharmacy license.
Section 333.17742 Section Disclosure; "applicant" defined.
Section 333.17742a Section Remote pharmacy; operation; licensure requirements; location waiver; exception.
Section 333.17742b Section Staffing of remote pharmacy; requirements; written policy and procedure manual; public notice display; operation requirements and limitations; "qualified pharmacy technician" defined.
Section 333.17743 Section Pharmacy license; contents; duration.
Section 333.17744 Section Designation of agent by prescriber; issuance of prescription; limitation; transmission of prescription to pharmacy.
Section 333.17744a Section Auto-injectable epinephrine; prescribing or issuing to authorizing entity.
Section 333.17744b Section Prescribing, possessing, or dispensing opioid antagonist; liability.
Section 333.17744c Section Person administering opioid antagonist under certain conditions; immunity from criminal prosecution or sanction.
Section 333.17744d Section Auto-injectable epinephrine; storage, maintenance, general oversight, and use by designated employee or agent; training program; certificate; liability; report; administration by person other than employee, agent, or individual described in subsection (2); "authorized health care provider" defined.
Section 333.17744e Section Dispensing opioid antagonist to individual pursuant to standing order issued by chief medical executive; "community-based organization" defined.
Section 333.17744f Section Dispensing emergency supply of insulin; requirements; limitation; liability; rules; definitions.
Section 333.17745 Section Drug control license; patient's chart or clinical record to include record of drugs dispensed; delegating authority to dispense drugs; storage of drugs; container; label; complimentary starter dose drug; information; compliance with MCL 333.7303a; inspection of locations; limitation on delegation; receipt of complimentary starter dose drugs by pharmacist; "complimentary starter dose" defined.
Section 333.17745a Section Definitions; public health program without on-site pharmacy; individuals delegated authority to dispense prescriptions; delegating delivery of certain oral contraceptives; circumstances; delegating delivery of methadone.
Section 333.17745b Section Industrial clinic or prescriber practice without on-site pharmacy; dispensing prescription drug.
Section 333.17746 Section Hospice emergency care services in patients' homes; medication box exchange program.
Section 333.17747 Section Drug control license; contents; duration; renewal; conditions; license as automatically void.
Section 333.17748 Section Pharmacy, manufacturer, wholesale distributor; or wholesale distributor-broker, license required; compounding services; renewal; designation of pharmacist in charge; joint responsibility; exemption; report of change in ownership, management, location, or PIC or facility manager; duties of pharmacist in charge; submission of fingerprints; criminal history check; exception; investigation or inspection of out-of-state applicant or compounding pharmacy; reimbursement for expenses.
Section 333.17748a Section Compounding services for sterile pharmaceuticals; accreditation; notification of complaint; maintenance and retention of records; resale of excess compounded pharmaceuticals prohibited; distribution of samples or complimentary starter doses; advertisement or promotion of compounding services; compounding pharmaceutical that is unavailable in marketplace; compounding and manufacturing at same location; rules.
Section 333.17748b Section Compounding nonsterile or sterile pharmaceuticals for prescriber or health facility or agency to administer to patients without prescription; authorization; report of adverse event; list of authorized pharmacies and pharmacists; selling or redispensing to prescriber or health facility or agency.
Section 333.17748c Section Compounding pharmaceutical; commercial availability.
Section 333.17748d Section Violation of MCL 333.17748a or 17748b; penality.
Section 333.17748e Section Out-of-state pharmacy; facilitation of delivery or trade; use of wholesale distributor-broker; requirements; liability; license requirements; transaction records; notification; investigation; definitions.
Section 333.17748f Section Licensure of a pharmacy as a wholesale distributor or manufacturer; requirements.
Section 333.17749 Section Dispensing of diagnostic or therapeutic pharmaceutical agents by wholesale distributor or pharmacist to optometrist; condition; “therapeutic pharmaceutical agent” and “diagnostic pharmaceutical agent” defined.
Section 333.17750 Section Person who distributes complimentary starter doses to prescribers; records; access by board; “complimentary starter dose” defined.
Section 333.17750a Section Dispensing of prescription for therapeutic pharmaceutical agent by pharmacist.
Section 333.17751 Section Dispensing prescription drug or device requiring prescription; requirements; exceptions.
Section 333.17752 Section Prescription or equivalent record; preservation; disclosure; providing copies; refilling copy; applicability of subsection (3) to pharmacies sharing real-time, on-line database and remote pharmacies; "equivalent record" defined.
Section 333.17753 Section Centralized prescription processing; conditions for performing or contracting; maintenance of policy and procedures manual; definition.
Section 333.17754 Section Electronic transmission of prescription; conditions; information; confidentiality; professional judgment as to accuracy, validity, and authenticity; original prescription; inapplicable after October 1, 2021.
Section 333.17754a Section Electronic transmission of prescription; conditions; information; confidentiality; professional judgment as to accuracy, validity, and authenticity; exceptions; waiver; rules; delayed implementation.
Section 333.17755 Section Dispensing lower cost generically equivalent drug product or interchangeable biological drug product; notice; contents of prescription label; limitation; restrictions; limitation on total charge; communication to be provided prescriber; exception; link on website to Purple Book; report; definitions.
Section 333.17756 Section Label on prescription; contents.
Section 333.17757 Section Price information; prohibited conduct; notice; receipt evidencing transactions; omission; retention of copy of receipt; rules.
Section 333.17757a Section Providing selling price of drugs dispensed upon request; notice to consumers about prescription drugs; contents; form; display; copies.
Section 333.17757b Section Contracts with pharmacy benefit managers; prohibited terms.
Section 333.17758 Section Repealed. 1986, Act 304, Eff. Mar. 31, 1987.
Section 333.17759 Section Dispensing harmful drug; requirements.
Section 333.17760 Section Operation of automated device not located at same address as pharmacy; control and supervision by pharmacist; delegation of tasks.
Section 333.17761 Section Display of notice; dispensing prescription in safety closure container.
Section 333.17762 Section Misbranded prescription.
Section 333.17763 Section Grounds for fine, reprimand, or probation; grounds for denying, limiting, suspending, or revoking license.
Section 333.17764 Section Conduct constituting misdemeanor; violation; penalty; other violations.
Section 333.17765 Section Adulteration or misbranding; guaranty or undertaking as protection against penalties for violation; exception; notice to seller, manufacturer, or wholesale distributor.
Section 333.17766 Section Additional conduct constituting misdemeanor.
Section 333.17766a Section Repealed. 2001, Act 236, Imd. Eff. Jan. 3, 2002.
Section 333.17766b Section Repealed. 2001, Act 231, Eff. Jan. 6, 2003.
Section 333.17766c Section Purchase or possession of ephedrine or pseudoephedrine or mixture prohibited; violation; penalty; exceptions.
Section 333.17766d Section Pharmacy operated by department of corrections or under contract with county jail; resale or redistribution of prescription drug; definitions.
Section 333.17766e Section Sale of ephedrine or pseudoephedrine; requirements of retail distributor; exceptions; violation; fine; report.
Section 333.17766f Section Possession of products containing ephedrine or pseudoephedrine; prohibited conduct; exceptions; violation; penalty; affirmative defense; rebuttal; conflict of local requirements with section.
Section 333.17766g Section Sale, trade, or purchase of dextromethorphan to minor; prohibition; exception for valid prescription; preemption; violation; civil infraction and fine.
Section 333.17767 Section Rules and determinations as to licensing.
Section 333.17768 Section Grounds for fine, reprimand, or probation, or for denying, limiting, suspending, or revoking license or ordering restitution or community service; applicability of subsection (2)(b).
Section 333.17770 Section Exceptions.
Section 333.17775 Section "Program for utilization of unused prescription drugs"; definitions; unused prescription drug repository and distribution program; rules; standards and procedures.
Section 333.17776 Section Destruction and disposal of certain drugs and medications.
Section 333.17780 Section Cancer drug repository program.